Previous 10 | Next 10 |
home / stock / tbpmf / tbpmf news
OTTAWA, ON / ACCESSWIRE / May 26, 2020 / Tetra Bio-Pharma Inc. ( "Tetra" or the "Company") (TSXV: TBP )(OTCQB: TBPMF ), a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development, announces granting of a new patent from the Australian Patent Office for pate...
Tetra Bio-Pharma Announces Closing of Public Offering Canada NewsWire OTTAWA, May 22, 2020 / NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / OTTAWA , May 22, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc. (" Tetra " ...
OTTAWA, ON / ACCESSWIRE / May 15, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development and ARTOFIX a Quebec City based high performance mask manufacturer are pleased to announce that Tetra has secu...
OTTAWA, May 15, 2020 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSXV:TBP) (OTCQB:TBPMF), is pleased to announce that, in connection with its previously announced overnight marketed offering, a syndicate of agents led by Raymond James Lt...
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES OTTAWA, May 14, 2020 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSXV:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and developm...
OTTAWA, ON / ACCESSWIRE / May 13, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, announces that its Board of Directors has accepted the resignation of Mr. Sylvain Chretien as President of the ...
OTTAWA, ON / ACCESSWIRE / May 11, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that its Chief Operating Officer Steeve Néron participated in an interview on Sat...
No adverse events observed in study participants Health Canada VDD grants trial renewal OTTAWA, ON / ACCESSWIRE / May 11, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) , a leader in cannabinoid-derived drug discovery and development, is pleased t...
OTTAWA, ON / ACCESSWIRE / May 8, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has engaged energi PR Inc. as its public relations firm, led by CEO, Carol Levi...
Phoenix, Arizona--(Newsfile Corp. - May 7, 2020) - The Stock Day Podcast welcomed Tetra Bio-Pharma (OTCQB: TBPMF) ("the Company"), a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed and approved, clinical program aim...
News, Short Squeeze, Breakout and More Instantly...
Tetra Bio-Pharma Inc Company Name:
TBPMF Stock Symbol:
OTCMKTS Market:
Tetra Bio-Pharma Inc Website:
(TheNewswire) Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) ( TSX:TBP ) ( OTC:TBPMF ) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development announced that...
(TheNewswire) MONTREAL, QUEBEC – TheNewswire – May 11, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development, today announced it has cancelled its New Drug Subm...
(TheNewswire) Montreal, QC - TheNewswire - March 10, 2023 - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1) , a leader in cannabinoid-derived drug discovery and development is pleased to announce Health Canada h...